Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology
Disease Category: Endometrial Cancer
Trial Information
ChemoFx® Observational Study in Gynecological Solid Tumors
Chemoresponse assays (lab test) measure the effect that chemotherapy treatment has on a patient's cancer cells in the lab. This test has shown success in a retrospective study in predicting how an individual patient's tumor will respond to a given chemotherapy. In a retrospective study, it was demonstrated that patients treated with a regimen that the test said that a patient's cells would be sensitive to, corresponds to a 3 times longer progression free interval. This study will look for trends and common factors among different people's cancer and their sensitivities to chemotherapy treatments.
Inclusion Criteria:
- Patients ≥ 18 years
- Confirmed gynecologic solid tumor malignancy
- Tissue specimen has been submitted to Precision Therapeutics, Inc. as part of the patient's medical care
- Be able to give written informed consent
Patricia Green Sharpe MSN MHSA RN, Director, Department of Clinical Trials/Oncology Data Services
Memorial Health University Medical Center
William & Iffath Hoskins Center for Biomedical Research & Education
4700 Waters Avenue
Savannah, GA 31404
Phone: 912 350-7887
Fax: 912 350-8183
EMail: sharppa1@memorialhealth.com
View Google Map
If you would like to learn more about participating in this study, please send an e-mail message using the form below.
DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the
clinical trials industry. The information provided in this service is designed
to help patients find clinical trials that may be of interest to them, and to
help patients contact the centers conducting the research. CenterWatch is
neither promoting this research nor involved in conducting any of these
trials.
